(YMAB) – Hot Corp. News
-
Y-mAbs Therapeutics (YMAB) Announces Restructuring Plan and Provides Financial Outlook Following CRL from FDA
-
Y-mAbs Therapeutics (YMAB) Disappointed by Outcome of Today’s FDA Advisory Committee Meeting on Omburtamab
Back to YMAB Stock Lookup